Published in Abdom Imaging on October 23, 2002
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Transjugular liver biopsy: What to do and what not to do. Indian J Radiol Imaging (2008) 0.91
Interventional radiology procedures in adult patients who underwent liver transplantation. World J Gastroenterol (2009) 0.84
Transjugular liver biopsy. Semin Intervent Radiol (2012) 0.83
Transjugular biopsy of an atypical focal nodular hyperplasia in a patient with acute liver failure clinical presentation. Emerg Radiol (2008) 0.82
Assessment of the efficacy and potential complications of transjugular liver biopsy in canine cadavers. J Vet Intern Med (2014) 0.75
Transjugular liver biopsy: results of 97 patients. Balkan Med J (2012) 0.75
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
Ultralong single-wall carbon nanotubes. Nat Mater (2004) 3.83
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst (1999) 3.46
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol (1989) 3.44
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer (1991) 2.98
Phytochelatin synthase genes from Arabidopsis and the yeast Schizosaccharomyces pombe. Plant Cell (1999) 2.74
Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med (1986) 2.70
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med (1979) 2.63
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
Incidence of high blood lead levels in Chicago children. Pediatrics (1969) 2.46
Mass screening for cancer of the breast. Lancet (1968) 2.33
Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst (1999) 2.25
Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol (1991) 2.13
Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Engl J Med (2001) 2.09
Occurrence of prostaglandin E2 in the human stomach, and a study of its effects on human isolated gastric muscle. Br J Pharmacol Chemother (1968) 2.02
Brain metastases from colorectal carcinoma. The long term survivors. Cancer (1996) 2.01
Rad18 is required for DNA repair and checkpoint responses in fission yeast. Mol Biol Cell (1999) 1.98
Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol (1991) 1.93
Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol (1994) 1.93
In vivo and in vitro analysis of ptl1, a yeast ts mutant with a membrane-associated defect in protein translocation. EMBO J (1988) 1.91
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones. Gut (1994) 1.83
Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients. Gastrointest Endosc (1995) 1.77
Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum (1996) 1.77
Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division. Proc Natl Acad Sci U S A (1999) 1.77
Malignant lymphoma of bone. Cancer (1986) 1.66
The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci (2000) 1.61
Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.59
Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer (1984) 1.52
Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry (1994) 1.51
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer (1986) 1.50
Treatment of prognosis of primary breast lymphoma: a review of 13 cases. Am J Clin Oncol (2000) 1.46
Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis. Gut (2004) 1.45
Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol (1993) 1.44
Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening. Eur J Gastroenterol Hepatol (2004) 1.44
Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol (2001) 1.42
The "dependent viscera" sign in CT diagnosis of blunt traumatic diaphragmatic rupture. AJR Am J Roentgenol (2001) 1.41
Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene (2001) 1.41
Diagnosis of pulmonary emboli and image quality at CT pulmonary angiography: influence of imaging direction with multidetector CT. Clin Radiol (2006) 1.40
"Golf ball liver": agent orange hepatitis. Gut (1997) 1.37
Intrahepatic hepatitis C viral RNA status of serum polymerase chain reaction-negative individuals with histological changes on liver biopsy. Hepatology (2001) 1.36
Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. Int J Radiat Oncol Biol Phys (1995) 1.35
Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg (1990) 1.34
Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology (1980) 1.33
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol (1997) 1.31
An initial approach to the taxonomy of some gram negative yellow pigmented rods. J Appl Bacteriol (1971) 1.31
Quality of life after myocardial infarction. J Clin Epidemiol (1994) 1.31
A single p34cdc2 protein kinase (encoded by nimXcdc2) is required at G1 and G2 in Aspergillus nidulans. J Cell Sci (1994) 1.30
Ambulatory treatment of lead poisoning: report of 1,155 cases. Pediatrics (1970) 1.28
Endoscopic management of common duct stones with laparoscopic cholecystectomy. Ir J Med Sci (1991) 1.27
Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum Mol Genet (1998) 1.25
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Ann Hematol (1992) 1.24
Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut (2002) 1.23
Bronchoscopic diagnosis of sarcoidosis. Eur Respir J (1997) 1.23
The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut (2005) 1.22
Postoperative follow-up of patients with carcinoma of the colon. Mayo Clin Proc (1983) 1.20
Use of sedation for routine diagnostic upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy Survey of National Endoscopy Society Members. Digestion (2006) 1.19
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. Br J Cancer (2009) 1.18
The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes. Biochem J (1985) 1.17
Raman spectroscopy and fluorescence photon migration for breast cancer diagnosis and imaging. Photochem Photobiol (1998) 1.16
Cut5 is a component of the UV-responsive DNA damage checkpoint in fission yeast. Mol Gen Genet (1998) 1.15
Lymphoma in macaques: association with virus of human T lymphotrophic family. Science (1984) 1.15
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Ann Intern Med (1979) 1.14
Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin. J Hepatol (1999) 1.14
Bile duct hamartomas (von Meyenburg complexes): value of MR imaging in diagnosis. Abdom Imaging (1999) 1.14
Varying intensity of postremission therapy in acute myeloid leukemia. Blood (1992) 1.13
Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol (1985) 1.13
Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer (1995) 1.12
A homologue of the Rad18 postreplication repair gene is required for DNA damage responses throughout the fission yeast cell cycle. Mol Genet Genomics (2001) 1.12
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol (2001) 1.12
Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells. Oncogene (1999) 1.11
Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc (1985) 1.10
Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer (2006) 1.09
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.09
Monitoring the fetal heart non-invasively: a review of methods. J Perinat Med (2001) 1.09
Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin). N Engl J Med (1987) 1.08
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol (1997) 1.07
Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology (1980) 1.06
Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence. J Urol (1999) 1.05
A NIMA homologue promotes chromatin condensation in fission yeast. J Cell Sci (1998) 1.05
Changes in the microbiology of vacuum-packaged beef. J Appl Bacteriol (1975) 1.05
Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med (1987) 1.05
Intraoperative and external beam irradiation +/- 5-FU for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (1987) 1.05
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol (1986) 1.03
Occurrence of prostaglandin E2 in the human stomach, and a study of its effects on human isolated gastric muscle. Br J Pharmacol Chemother (1968) 1.03
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. N Engl J Med (1992) 1.03
A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer. Cancer (1991) 1.02
Characterization of pigs transgenic for human decay-accelerating factor. Transplantation (1997) 1.01
Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol (1999) 1.01
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998). Cancer (1974) 1.01
Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection. J Med Virol (2003) 1.00
Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival, and prognostic factors. Int J Radiat Oncol Biol Phys (1989) 1.00
Primary bone lymphoma: single institution case series. Ir J Med Sci (2008) 0.99
Intraoperative and external beam irradiation for locally advanced colorectal cancer. Ann Surg (1988) 0.98